General Information of the Compound
| Compound ID |
CP0440062
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-3-methylbenzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H24FN3O3S
|
||||||||||||||||||
| Molecular Weight |
417.506
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(c1)S(=O)(=O)NCCN1CCC(CC1)c1noc2cc(F)ccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H24FN3O3S/c1-15-3-2-4-18(13-15)29(26,27)23-9-12-25-10-7-16(8-11-25)21-19-6-5-17(22)14-20(19)28-24-21/h2-6,13-14,16,23H,7-12H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
KJWQBYGNNGUYBM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor